FDA Drug Application (017743) for BREVICON 28-DAY by ALLERGAN SALES LLC

Back to FDA Applications sponsored by ALLERGAN SALES LLC

Application Number017743
Product Number001
FormTABLET;ORAL-28
Dosage0.035MG;0.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameBREVICON 28-DAY
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE



Back to FDA Applications sponsored by ALLERGAN SALES LLC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.